Revenue | ₹210.05Cr |
Net Profits | ₹15.54Cr |
Net Profit Margins | 7.40% |
Bliss GVS Pharma Ltd’s revenue jumped 3.1% since last year same period to ₹210.05Cr in the Q4 2024-2025. On a quarterly growth basis, Bliss GVS Pharma Ltd has generated -6.93% fall in its revenue since last 3-months.
Bliss GVS Pharma Ltd’s net profit jumped 269.84% since last year same period to ₹15.54Cr in the Q4 2024-2025. On a quarterly growth basis, Bliss GVS Pharma Ltd has generated -34.71% fall in its net profits since last 3-months.
Bliss GVS Pharma Ltd’s net profit margin jumped 264.73% since last year same period to 7.40% in the Q4 2024-2025. On a quarterly growth basis, Bliss GVS Pharma Ltd has generated -29.85% fall in its net profit margins since last 3-months.
The revenue for Bliss GVS Pharma Ltd in the Q4 results 2024 was ₹210.05Cr.
The net profit for Bliss GVS Pharma Ltd in the Q4 results 2024 was ₹15.54Cr.
The net profit margin for Bliss GVS Pharma Ltd in the Q4 results 2024 was 7.40%.
The revenue for Bliss GVS Pharma Ltd in the Q4 results 2023 was ₹203.73Cr.
The net profit for Bliss GVS Pharma Ltd in the Q4 results 2023 was ₹-9.15Cr.
The net profit margin for Bliss GVS Pharma Ltd in the Q4 results 2023 was -4.49%.